Global Pediatric Drugs Market Research Report 2021

1 Pediatric Drugs Market Overview

• 1.1 Product Overview and Scope of Pediatric Drugs
• 1.2 Pediatric Drugs Segment by Type
  • 1.2.1 Global Pediatric Drugs Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Allergy and Respiratory Drugs
  • 1.2.3 Anti-Infectives
  • 1.2.4 Cancer Therapies
  • 1.2.5 Cardiovascular Drugs
  • 1.2.6 Central Nervous System Drugs
  • 1.2.7 Gastrointestinal Drugs
  • 1.2.8 Hormone Drugs
  • 1.2.9 Urological Drugs
• 1.3 Pediatric Drugs Segment by Application
  • 1.3.1 Pediatric Drugs Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Drugstore
• 1.4 Global Pediatric Drugs Market Size Estimates and Forecasts
  • 1.4.1 Global Pediatric Drugs Revenue 2016-2027
  • 1.4.2 Global Pediatric Drugs Sales 2016-2027
  • 1.4.3 Pediatric Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Pediatric Drugs Market Competition by Manufacturers

• 2.1 Global Pediatric Drugs Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Pediatric Drugs Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Pediatric Drugs Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Pediatric Drugs Manufacturing Sites, Area Served, Product Type
• 2.5 Pediatric Drugs Market Competitive Situation and Trends
  • 2.5.1 Pediatric Drugs Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Pediatric Drugs Players Market Share by Revenue
  • 2.5.3 Global Pediatric Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pediatric Drugs Retrospective Market Scenario by Region

• 3.1 Global Pediatric Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Pediatric Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Pediatric Drugs Market Facts & Figures by Country
  • 3.3.1 North America Pediatric Drugs Sales by Country
  • 3.3.2 North America Pediatric Drugs Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Pediatric Drugs Market Facts & Figures by Country
  • 3.4.1 Europe Pediatric Drugs Sales by Country
  • 3.4.2 Europe Pediatric Drugs Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Pediatric Drugs Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Pediatric Drugs Sales by Region
  • 3.5.2 Asia Pacific Pediatric Drugs Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Pediatric Drugs Market Facts & Figures by Country
  • 3.6.1 Latin America Pediatric Drugs Sales by Country
  • 3.6.2 Latin America Pediatric Drugs Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Pediatric Drugs Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Pediatric Drugs Sales by Country
  • 3.7.2 Middle East and Africa Pediatric Drugs Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Pediatric Drugs Historic Market Analysis by Type

• 4.1 Global Pediatric Drugs Sales Market Share by Type (2016-2021)
• 4.2 Global Pediatric Drugs Revenue Market Share by Type (2016-2021)
• 4.3 Global Pediatric Drugs Price by Type (2016-2021)

5 Global Pediatric Drugs Historic Market Analysis by Application

• 5.1 Global Pediatric Drugs Sales Market Share by Application (2016-2021)
• 5.2 Global Pediatric Drugs Revenue Market Share by Application (2016-2021)
• 5.3 Global Pediatric Drugs Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Abbott Laboratories
  • 6.1.1 Abbott Laboratories Corporation Information
  • 6.1.2 Abbott Laboratories Description and Business Overview
  • 6.1.3 Abbott Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Abbott Laboratories Product Portfolio
  • 6.1.5 Abbott Laboratories Recent Developments/Updates
• 6.2 Bayer
  • 6.2.1 Bayer Corporation Information
  • 6.2.2 Bayer Description and Business Overview
  • 6.2.3 Bayer Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Bayer Product Portfolio
  • 6.2.5 Bayer Recent Developments/Updates
• 6.3 Boehringer Ingelheim
  • 6.3.1 Boehringer Ingelheim Corporation Information
  • 6.3.2 Boehringer Ingelheim Description and Business Overview
  • 6.3.3 Boehringer Ingelheim Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Boehringer Ingelheim Product Portfolio
  • 6.3.5 Boehringer Ingelheim Recent Developments/Updates
• 6.4 Bristol-Myers Squibb
  • 6.4.1 Bristol-Myers Squibb Corporation Information
  • 6.4.2 Bristol-Myers Squibb Description and Business Overview
  • 6.4.3 Bristol-Myers Squibb Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Bristol-Myers Squibb Product Portfolio
  • 6.4.5 Bristol-Myers Squibb Recent Developments/Updates
• 6.5 Colgate Oral Pharmaceuticals
  • 6.5.1 Colgate Oral Pharmaceuticals Corporation Information
  • 6.5.2 Colgate Oral Pharmaceuticals Description and Business Overview
  • 6.5.3 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Colgate Oral Pharmaceuticals Product Portfolio
  • 6.5.5 Colgate Oral Pharmaceuticals Recent Developments/Updates
• 6.6 Eli Lilly
  • 6.6.1 Eli Lilly Corporation Information
  • 6.6.2 Eli Lilly Description and Business Overview
  • 6.6.3 Eli Lilly Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Eli Lilly Product Portfolio
  • 6.6.5 Eli Lilly Recent Developments/Updates
• 6.7 Forest Laboratories
  • 6.6.1 Forest Laboratories Corporation Information
  • 6.6.2 Forest Laboratories Description and Business Overview
  • 6.6.3 Forest Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Forest Laboratories Product Portfolio
  • 6.7.5 Forest Laboratories Recent Developments/Updates
• 6.8 Genentech
  • 6.8.1 Genentech Corporation Information
  • 6.8.2 Genentech Description and Business Overview
  • 6.8.3 Genentech Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Genentech Product Portfolio
  • 6.8.5 Genentech Recent Developments/Updates
• 6.9 GlaxoSmithKline
  • 6.9.1 GlaxoSmithKline Corporation Information
  • 6.9.2 GlaxoSmithKline Description and Business Overview
  • 6.9.3 GlaxoSmithKline Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 GlaxoSmithKline Product Portfolio
  • 6.9.5 GlaxoSmithKline Recent Developments/Updates
• 6.10 Johnson & Johnson
  • 6.10.1 Johnson & Johnson Corporation Information
  • 6.10.2 Johnson & Johnson Description and Business Overview
  • 6.10.3 Johnson & Johnson Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Johnson & Johnson Product Portfolio
  • 6.10.5 Johnson & Johnson Recent Developments/Updates
• 6.11 MedImmune
  • 6.11.1 MedImmune Corporation Information
  • 6.11.2 MedImmune Pediatric Drugs Description and Business Overview
  • 6.11.3 MedImmune Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 MedImmune Product Portfolio
  • 6.11.5 MedImmune Recent Developments/Updates
• 6.12 Merck
  • 6.12.1 Merck Corporation Information
  • 6.12.2 Merck Pediatric Drugs Description and Business Overview
  • 6.12.3 Merck Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Merck Product Portfolio
  • 6.12.5 Merck Recent Developments/Updates
• 6.13 Novartis Pharmaceuticals
  • 6.13.1 Novartis Pharmaceuticals Corporation Information
  • 6.13.2 Novartis Pharmaceuticals Pediatric Drugs Description and Business Overview
  • 6.13.3 Novartis Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Novartis Pharmaceuticals Product Portfolio
  • 6.13.5 Novartis Pharmaceuticals Recent Developments/Updates
• 6.14 Novo Nordisk
  • 6.14.1 Novo Nordisk Corporation Information
  • 6.14.2 Novo Nordisk Pediatric Drugs Description and Business Overview
  • 6.14.3 Novo Nordisk Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Novo Nordisk Product Portfolio
  • 6.14.5 Novo Nordisk Recent Developments/Updates
• 6.15 Pfizer
  • 6.15.1 Pfizer Corporation Information
  • 6.15.2 Pfizer Pediatric Drugs Description and Business Overview
  • 6.15.3 Pfizer Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Pfizer Product Portfolio
  • 6.15.5 Pfizer Recent Developments/Updates
• 6.16 Pharmacia
  • 6.16.1 Pharmacia Corporation Information
  • 6.16.2 Pharmacia Pediatric Drugs Description and Business Overview
  • 6.16.3 Pharmacia Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Pharmacia Product Portfolio
  • 6.16.5 Pharmacia Recent Developments/Updates
• 6.17 Roche
  • 6.17.1 Roche Corporation Information
  • 6.17.2 Roche Pediatric Drugs Description and Business Overview
  • 6.17.3 Roche Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Roche Product Portfolio
  • 6.17.5 Roche Recent Developments/Updates
• 6.18 Schering-Plough
  • 6.18.1 Schering-Plough Corporation Information
  • 6.18.2 Schering-Plough Pediatric Drugs Description and Business Overview
  • 6.18.3 Schering-Plough Pediatric Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Schering-Plough Product Portfolio
  • 6.18.5 Schering-Plough Recent Developments/Updates

7 Pediatric Drugs Manufacturing Cost Analysis

• 7.1 Pediatric Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Pediatric Drugs
• 7.4 Pediatric Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Pediatric Drugs Distributors List
• 8.3 Pediatric Drugs Customers

9 Pediatric Drugs Market Dynamics

• 9.1 Pediatric Drugs Industry Trends
• 9.2 Pediatric Drugs Growth Drivers
• 9.3 Pediatric Drugs Market Challenges
• 9.4 Pediatric Drugs Market Restraints

10 Global Market Forecast

• 10.1 Pediatric Drugs Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Pediatric Drugs by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Pediatric Drugs by Type (2022-2027)
• 10.2 Pediatric Drugs Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Pediatric Drugs by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Pediatric Drugs by Application (2022-2027)
• 10.3 Pediatric Drugs Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Pediatric Drugs by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Pediatric Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List